Home
Addax Petroleum Announces Update To Gabon Drilling Program

Addax Petroleum Announces Update To Gabon Drilling Program

Jan 09 2009 | comment(s)

CALGARY, Canada, January 9 /PRNewswire/ --

- Successful Appraisal and Development Wells in Etame Marin License Area

Addax Petroleum Corporation (Addax Petroleum or the Corporation) (TSX:AXC and LSE:AXC) today announces the successful appraisal and development of the Ebouri field in the Etame Marin license area offshore Gabon. Addax Petroleum has a 31.36 per cent non-operated interest in the Etame Marin license area.

Itanium(R) Solutions Alliance Drives Momentum In Mission-Critical Computing

Itanium(R) Solutions Alliance Drives Momentum In Mission-Critical Computing

Jan 09 2009 | comment(s)

PORTLAND, Oregon, January 9 /PRNewswire/ --

- Global gains and major milestones mark successful 2008

The Itanium(R) Solutions Alliance marked a year of accomplishment as Itanium-based systems saw increased migration from legacy mainframes and earned continued success in the mission-critical and computationally intensive arenas. The Alliance and the Itanium platform continue to gain momentum as enterprise IT organizations upgrade infrastructure to take advantage of increased performance and reduced cost of ownership and markets take greater advantage of high-powered Itanium-based server technology.

ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development In Osteoarthritis With The Potential For Disease-Modifying Activity

ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development In Osteoarthritis With The Potential For Disease-Modifying Activity

Jan 09 2009 | comment(s)

ZURICH, Switzerland, January 9 /PRNewswire/ --

ESBATech AG, a leading developer of antibody fragment therapeutics, today announced the initiation of the Phase I/IIa clinical development of its anti-TNF alpha antibody fragment ESBA105 in osteoarthritis (OA). This double-blind, randomized, placebo-controlled Phase I/IIa clinical study is designed to investigate the safety, tolerability and efficacy on pain with ESBA105 applied locally via intra-articular administration to patients with severely painful OA of the knee. The multicenter study is initiated at various sites across Switzerland.

Victory Pharma Announces Launch Of Additional NAPRELAN(R) Prescription Products

Victory Pharma Announces Launch Of Additional NAPRELAN(R) Prescription Products

Jan 09 2009 | comment(s)

SAN DIEGO, January 9 /PRNewswire/ --

Victory Pharma, Inc., a privately held specialty pharmaceutical company, today announced that it is launching two additional dosage strengths of NAPRELAN(R) (naproxen sodium) Controlled-Release Tablets. NAPRELAN is a once-daily, controlled-release formulation of naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of a number of conditions, including osteoarthritis, rheumatoid arthritis and management of mild to moderate pain. VICTORY'S promotional efforts will be directed primarily at pain management specialists, rheumatologists, orthopedic surgeons and selected primary care physicians.

Endeavour Launches Onshore U.S. Exploration Campaign

Endeavour Launches Onshore U.S. Exploration Campaign

Jan 09 2009 | comment(s)

HOUSTON, January 9 /PRNewswire/ --

- First South Texas well results in commercial discovery and first U.S. production

Endeavour International Corporation (Amex: END) (LSE: ENDV) announced today that the first exploration well of a new onshore exploration program focused in South Texas has resulted in a commercial discovery and the company's first production in the United States. The initiative reflects a shift in strategy by Endeavour to pursue opportunities with shorter cycle times and lower costs that complement its growing North Sea asset base.

Be Free From Exam Nerves

Be Free From Exam Nerves

Jan 09 2009 | comment(s)

LONDON, January 9 /PRNewswire/ --

- New Online Service Provides the Best Chance of Excelling in Examinations and Tests at Whatever Age

A new website has been launched by the Be Free From Partnership. It is designed specifically to get rid of all examination, test and interview nerves. The service is EXAM AID and it can be found at http://www.befreefrom.com. The website gives detailed personalized instruction, there and then, on how to get rid of exam and test nerves. At the end it provides a free optional print out of the personalised instructions for later use. It costs GBP10 and if the instructions do not work, the company offer a 'no quibble' money back guarantee.

ThromboGenics Begins Phase III Program With Microplasmin For The Non-surgical Treatment Of Back Of The Eye Disease

ThromboGenics Begins Phase III Program With Microplasmin For The Non-surgical Treatment Of Back Of The Eye Disease

Jan 09 2009 | comment(s)

LEUVEN, Belgium, January 9 /PRNewswire/ --

- ThromboGenics' Lead Product to be Studied in the Treatment of Vitreomacular Adhesion in the US and Europe

Galileo's Telescope Recreated

Galileo's Telescope Recreated

Jan 09 2009 | comment(s)

In 1609, 400 years ago, Galileo revolutionized humankind's understanding of our position in the Universe when he used a telescope for the first time to study the heavens and sketched radical new views of the moon and also discovering the satellites orbiting Jupiter.

To celebrate the International Year of Astronomy (IYA), which marks the anniversary of Galileo's discoveries, a group of astronomers and curators from the Arcetri Observatory and the Institute and Museum of the History of Science, both in Florence, Italy, are recreating the kind of telescope and conditions that led to Galileo's world-changing observations, reports January's Physics World.
Spirituality, Not Religion, Makes Kids Happy, Say Psychologists

Spirituality, Not Religion, Makes Kids Happy, Say Psychologists

Jan 09 2009 | comment(s)

To make children happier, we may need to encourage them to develop a strong sense of 'personal worth', according to Dr. Mark Holder, Associate Professor at the University of British Columbia,  Visiting Assistant Professor Dr. Ben Coleman and graduate student Judi Wallace.   Their research says that children who feel that their lives have meaning and value and who develop deep, quality relationships – what they term measures of spirituality – are happier.

But according to their paper in the Journal of Happiness Studies, actual religious practices have little effect on that happiness.
Just Maybe, Obesity Is In Your Head

Just Maybe, Obesity Is In Your Head

Jan 09 2009 | comment(s)

6 newly discovered genes for obesity have a neural effect, according to the international GIANT (Genetic Investigation of Anthropometric Parameters) consortium.

So far, the scientists have analyzed two million DNA variations in 15 genome-wide association studies with a total of more than 32,000 participants and the identified candidate genes were validated in 14 further studies including 59,000 participants.

In addition to the FTO and MC4R genes already known, it was now possible for six more obesity genes to be identified: TMEM18, KCTD15, GNPDA2, SH2B1, MTCH2, and NEGR1.